510(k) Report

510(k) · Cleared

Cleared

U2 Total Knee System-PF+

K221705510(k) TraditionalCleared Feb 28, 2023260-day reviewClass II21 CFR 888.3565

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

United Orthopedic Corporation · MBH Prosthesis, Knee, Patello/Femorotibial, Semi-Constrained, Uncemented, Porous, Coated, Polymer/Metal/Polymer

Cleared on Feb 28, 2023 as substantially equivalent to K140075 (United Orthopedic Corp., 2014) and 1 other predicate after a 260-day review. Its family tree reaches back 4 generations to 1995. 1 later device descends from it.

Decided
Feb 28, 2023
Review
260 days
Class
Class II
Product code
MBH
Recalls
None
Predicates
2

Its longest line of descent runs back 4 generations to K951987 (1995). 7 ancestors in all. 1 later device descends from it, 1 citing it directly.

  1. Root · 4 generations backK951987 Genesis II Total Knee SystemSmith & Nephew Richards, Inc. · 1995 · Recalled
  2. 3 generations backK030612 Genesis II Total Knee SystemSmith & Nephew, Inc. · 2003
  3. 2 generations backK140075 U2 Femoral Component, CR, Porous CoatedUnited Orthopedic Corp. · 2014
  4. 1 generation backK150832 U2 Femoral Component, CR, Porous Coated, Additional SizesUnited Orthopedic Corporation · 2015
  5. This deviceK221705 U2 Total Knee System-PF+United Orthopedic Corporation · 2023
  6. Descendant · cites it directly · 0 of its ownK243656 U2 Total Knee System – PF+ Patella; USTAR II System– PF+ PatellaUnited Orthopedic Corporation · 2025

Most influential descendants

Showing 1 of 1 · See all
  • K243656U2 Total Knee System – PF+ Patella; USTAR II System– PF+ PatellaUnited Orthopedic Corporation · 2025 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K951987Genesis II Total Knee SystemSmith & Nephew Richards, Inc.19956
−3K030612Genesis II Total Knee SystemSmith & Nephew, Inc.2003—
−2K140075U2 Femoral Component, CR, Porous CoatedUnited Orthopedic Corp.2014—
−1K150832U2 Femoral Component, CR, Porous Coated, Additional SizesUnited Orthopedic Corporation2015—
0 (this device)K221705U2 Total Knee System-PF+United Orthopedic Corporation2023—
+1K243656U2 Total Knee System – PF+ Patella; USTAR II System– PF+ PatellaUnited Orthopedic Corporation2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199610
200210
200610

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202510
FIG. 1 — Lineage of K221705, 1995–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MBH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MBH device

  1. #1 K241597 Freedom® Total Knee System - Porous Tibial…score 19.9 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K140075U2 Femoral Component, CR, Porous Coated
Summary page 4
…ate Product name Manufacturer 510(k) Number U2 Femoral Component, CR, Porous United Orthopedic Corporation K140075, K150832 Coated Predicate or Reference Device U2 Total Knee System United Orthopedic Corporation K0516…
United Orthopedic Corp.2014—
*K150832U2 Femoral Component, CR, Porous Coated, Additional Sizes
Summary page 4
…uct name Manufacturer 510(k) Number U2 Femoral Component, CR, Porous United Orthopedic Corporation K140075, K150832 Coated Predicate or Reference Device U2 Total Knee System United Orthopedic Corporation K051640, K1205…
United Orthopedic Corporation2015—
†K051640U2 Total Knee SystemUnited Orthopedic Corp.20061
†K120507United U2 Femoral Component, PS, #7United Orthopedic Corporation20121
†K181794Truliant Porous Femoral ComponentsExactech, Inc.2018—
†K123486Triathlon Tritanium Tibial BaseplateStryker20137
†K162256Klassic Femur, Porous, Klassic Tibial Baseplate, PorousTotal Joint Orthopedics, Inc.2016—
†K140942Klassic Knee Tibial Stem ExtensionTotal Joint Orthopedics, Inc.2014—
†K190100USTAR II SystemUnited Orthopedic Corporation20195
†K151316U2 Hip Stem, Ti Porous Coated, MatrixUnited Orthopedic Corporation2015—

Also cleared against K140075: 1 other device →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K243656U2 Total Knee System – PF+ Patella; USTAR II System– PF+ PatellaUnited Orthopedic Corporation20250

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 28 years and passes through 4 companies; a new generation was cleared every 7.8 years on median.
  • 2 of the 7 ancestors have a recall of any class.
  • Of its descendants, K243656 (United Orthopedic Corporation, 2025) has gone furthest, with 0 descendants of its own.
  • 1 other device also cites its predicate K140075.

How does its category compare?

All MBH devices

MBH Prosthesis, Knee, Patello/Femorotibial, Semi-Constrained, Uncemented, Porous, Coated, Polymer/Metal/Polymer: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · MBH

8in 2025

2007: 102008: 32009: 32010: 42011: 52012: 52013: 62014: 92015: 82016: 42017: 42018: 62019: 12020: 72021: 62022: 72023: 62024: 102025: 82026 (partial year): 7
2007high 10 (2007) · low 1 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MBH

98in 2025

2007: 59 days median2008: 70 days median2009: 209 days median2010: 84 days median2011: 84 days median2012: 90 days median2013: 138 days median2014: 114 days median2015: 100 days median2016: 74 days median2017: 115 days median2018: 89 days median2020: 112 days median2021: 48 days median2022: 57 days median2023: 94 days median2024: 84 days median2025: 98 days median2026 (partial year): 153 days median
2007high 209 (2009) · low 48 (2021)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MBH

1in 2024

2009: 22011: 152012: 1, 1 Class I2013: 4, 4 Class I2016: 12017: 92018: 12019: 12020: 22023: 22024: 12026 (partial year): 4
2007high 15 (2011) · low 0 (2007)2026

Class I (5 since 2007) Class II/III not classified

Adverse event reports per year · MBH

1,561in 2025

2007: 272008: 212009: 892010: 1212011: 2472012: 3702013: 3082014: 3852015: 9552016: 1,0342017: 1,0072018: 1,1912019: 1,3942020: 1,0892021: 1,5392022: 1,2612023: 1,2632024: 1,4972025: 1,561
2007high 1,561 (2025) · low 21 (2008)2025

MAUDE reports naming product code MBH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071059027
2008370021
20093209289
20104840121
201158415247
20125901 (1)370
201361384 (4)308
201491140385
201581000955
201647411,034
2017411591,007
201868911,191
20191—11,394
2020711221,089
202164801,539
202275701,261
202369421,263
2024108411,497
202589801,561
202671534—

What is it indicated for?

U2 Total Knee System - PF+ is indicated in knee arthroplasty for reduction or relief of pain and/or improved knee function in skeletally mature patients with severe knee pain and disability due to rheumatoid arthritis, osteoarthritis, primary and secondary traumatic arthritis, polyarthritis, collagen disorders, avascular necrosis of the femoral condyle or pseudogout, posttraumatic loss of joint configuration, particularly when there is patellofemoral…

Read the full statement (124 words)

U2 Total Knee System - PF+ is indicated in knee arthroplasty for reduction or relief of pain and/or improved knee function in skeletally mature patients with severe knee pain and disability due to rheumatoid arthritis, osteoarthritis, primary and secondary traumatic arthritis, polyarthritis, collagen disorders, avascular necrosis of the femoral condyle or pseudogout, posttraumatic loss of joint configuration, particularly when there is patellofemoral joint surface erosion, dysfunction or prior patellectomy, moderate valgus, varus, or flexion deformities. This device may also be indicated in the salvage or previously failed surgical attempts or for knee in which satisfactory stability in flexion cannot be obtained at the time of surgery. Femoral Component, PF+, Tibial Baseplate, PF+ and Tibial Extension Stem are indicated for both cemented and cementless use.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K221705: U2 Total Knee System-PF+.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K221705

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026